-
Mashup Score: 0
Rana McKay, MD, University of California San Diego, San Diego, CA, outlines the results of a biomarker analysis from a…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Hala Borno, MD, BS, University of California San Francisco, San Francisco, CA, outlines the impact of the COVID-19 pandemic on…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Assessing the impact of the #COVID19 pandemic on patients with genitourinary cancer w/ @HalaBorno of @UCSF Watch here 👉 https://t.co/Ar7nC5m3u4👈 @VJOncology @OncoAlert @ASCO #GU21 #GUsm #OncoAlert #MedOnc #ClinOnc #NCRM21 #ResearchSavesLives #Oncology
-
-
Mashup Score: 1CheckMate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for RCC - 3 year(s) ago
Rana McKay, MD, University of California San Diego, San Diego, CA, outlines results from the Phase III CheckMate 214 trial…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: CheckMate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for #KidneyCancer w/ @DrRanaMcKay of @UCSanDiego Watch here 👉https://t.co/HM7bhgV9C0👈 @VJOncology @OncoAlert @ASCO #GU21 #GUsm #KCsm #UroOnc #OncoAlert #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 6
Join members of the Cancer.Net Editorial Board for a free 1-hour webinar about new research in prostate, bladder, kidney, and testicular cancers presented at this year’s ASCO Annual Meeting and Genitourinary Cancers Symposium. This webinar is intended for people with cancer and their families and caregivers. In it, Neeraj Agarwal, MD (Huntsman Cancer Institute and University of Utah), Petros…
Source: Zoom VideoCategories: Hem/Oncs, Latest HeadlinesTweet-
Thrilled to announce the 1st @CancerDotNet Research Round-Up on 6/16/21 at 1PM ET. Our #GU ed board conceived of this as a means of conveying #ASCO21 & #GU21 updates directly to the most impt stakeholder - our pts & their families. Please register here: https://t.co/jQ8tretYcK https://t.co/il2J5JkWwl
-
-
Mashup Score: 0Enfortumab vedotin in urothelial cancer - 3 year(s) ago
Arlene Siefker-Radtke, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of the antibody-drug conjugate, enfortumab…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Enfortumab vedotin in urothelial cancer w/ Arlene Siefker-Radtke of @MDAndersonNews Watch here 👉 https://t.co/JZ1oDU7DLD👈 @VJOncology @OncoAlert @ASCO #GU21 #GUsm #BLCsm #UroOnc #UroSoMe #OncoAlert #MedOnc #ClinOnc #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 1
Jana McHugh, MD, of The Institute of Cancer Research, London, UK, gives a brief background of the BARCODE1 (NCT03857477) pilot…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Using the polygenic risk score for targeted prostate cancer screening w/ Jana McHugh of @ICR_London Watch here 👉 https://t.co/KKXvdeCvaz👈 @VJOncology @OncoAlert @ASCO #GU21 #UroSoMe #UroOnc #ProstateCancer #PCsm #Oncology #OncoAlert #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0Emerging treatment options for patients with prostate cancer - 3 year(s) ago
Jana McHugh, MD, of The Institute of Cancer Research, London, UK, discusses exciting new treatment options for prostate cancer, such…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Emerging treatment options for patients with prostate cancer w/ Jana McHugh of @ICR_London 👉 https://t.co/qg9aYoQVsv👈 @VJOncology @OncoAlert @ASCO #GU21 #UroSoMe #UroOnc #ProstateCancer #PCsm #Oncology #OncoAlert #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0
Frédéric Pouliot, MD, PhD, FRCSC, University Hospital of Quebec and Laval University, Quebec, Canada, outlines the results of the Phase…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: 18F-DCFPyL PET/CT imaging up-stages patients with #ProstateCancer w/ Frédéric Pouliot of @chudequebec 👉 https://t.co/evgeBXLF88👈 @VJOncology @OncoAlert @ASCO #GU21 #GUsm #PCsm #UroOnc #UroSoMe #Oncology #MedOnc #OncoAlert #TrialUpdate #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0TERTp mutations as prognostic markers in urothelial cancer - 3 year(s) ago
Vadim Koshkin, MD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses the use of TERT promoter (TERTp)…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: TERTp mutations as prognostic markers in urothelial cancer w/ @koshkin85 of @UCSFCancer 👉 https://t.co/PTtuuKVC1q👈 @VJOncology @OncoAlert @ASCO #GU21 #GUsm #BLCsm #UroOnc #UroSoMe #Oncology #ClinOnc #MedOnc #OncoAlert #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0
Frédéric Pouliot, MD, PhD, FRCSC, University Hospital of Quebec and Laval University, Quebec, Canada, shares an update on the Phase…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: ARROW: PSMA-targeted radioligand therapy plus enzalutamide in mCRPC w/ Frédéric Pouliot of @chudequebec 👉 https://t.co/rUIZGNEyq7👈 @VJOncology @OncoAlert @ASCO #GU21 #GUsm #ProstateCancer #PCsm #UroOnc #Oncology #OncoAlert #TrialUpdate #NCRM21 #ResearchSavesLives
-
VIDEO: Biomarker analysis of olaparib with or without cediranib in mCRPC w/ @DrRanaMcKay of @UCSanDiego Watch here 👉 https://t.co/Dnto7w2CVU👈 @VJOncology @OncoAlert @ASCO #GU21 #GUsm #PCsm #ProstateCancer #UroOnc #UroSoMe #OncoAlert #MedOnc #NCRM21 #ResearchSavesLives